Efficacy of intrathecal bupivacaine: how important is the flow rate?

We present two cases of cancer patients with intractable mechanical and visceral pain that was unrelieved with either comprehensive medical management or intrathecal morphine who received intrathecal bupivacaine. While the continuous administration of a seemingly significant daily dose neither relieved pain nor caused measurable clinical changes, the addition of small, presumably negligible bolus doses on top of the continuous infusion resulted in spectacular pain control, clear thermoanalgesic suspended block, and in one of the patients, significant hypotension. To the best of our knowledge, such an observation has neither been reported before nor can we provide a satisfactory explanation for it. However, we believe it may have significant implications for the treatment of some patients, in particular, cancer patients with mechanical pain that cannot be adequately relieved with morphine whatever the route of administration.

[1]  P. Maeder,et al.  Spinal cord lesion after long-term intrathecal clonidine and bupivacaine treatment for the management of intractable pain , 2004, Pain.

[2]  S. Shafer,et al.  Cephalad Movement of Morphine and Fentanyl in Humans after Intrathecal Injection , 2003, Anesthesiology.

[3]  N. Rainov,et al.  Patient‐controlled Analgesia in Intrathecal Therapy for Chronic Pain: Safety and Effective Operation of the Model 8831 Personal Therapy Manager with a Pre‐implanted SynchroMed Infusion System , 2003, Neuromodulation : journal of the International Neuromodulation Society.

[4]  C. Sommer,et al.  Chronically Infused Intrathecal Morphine in Dogs , 2003, Anesthesiology.

[5]  Y. E. Mironer,et al.  Efficacy and Safety of Intrathecal Opioid/Bupivacaine Mixture in Chronic Nonmalignant Pain: A Double Blind, Randomized, Crossover, Multicenter Study by the National Forum of Independent Pain Clinicians (NFIPC) , 2002, Neuromodulation : journal of the International Neuromodulation Society.

[6]  S. Hassenbusch,et al.  Intrathecal Bupivacaine for Chronic Pain: A Review of Current Knowledge , 2002, Neuromodulation : journal of the International Neuromodulation Society.

[7]  R. Coffey,et al.  Inflammatory Mass Lesions Associated with Intrathecal Drug Infusion Catheters: Report and Observations on 41 Patients , 2001, Neurosurgery.

[8]  N Alperin,et al.  Hydrodynamic modeling of cerebrospinal fluid motion within the spinal cavity. , 2000, Journal of biomechanical engineering.

[9]  Michael E. Johnson,et al.  Potential neurotoxicity of spinal anesthesia with lidocaine. , 2000, Mayo Clinic proceedings.

[10]  S. Hassenbusch,et al.  Current practices in intraspinal therapy--a survey of clinical trends and decision making. , 2000, Journal of pain and symptom management.

[11]  S. Hassenbusch,et al.  Evidence-based review of the literature on intrathecal delivery of pain medication. , 2000, Journal of pain and symptom management.

[12]  J. Neal,et al.  The neurotoxicity of drugs given intrathecally (spinal) , 1999, Anesthesia and analgesia.

[13]  I. Curelaru,et al.  Continuous Intracisternal and High Cervical Intrathecal Bupivacaine Analgesia in Refractory Head and Neck Pain , 1996, Anesthesiology.

[14]  H. Wulf,et al.  The stability of mixtures of morphine hydrochloride, bupivacaine hydrochloride, and clonidine hydrochloride in portable pump reservoirs for the management of chronic pain syndromes. , 1994, Journal of Pain and Symptom Management.

[15]  D. Greitz,et al.  On the Pulsatile Nature of Intracranial and Spinal CSF-Circulation Demonstrated by MR Imaging , 1993, Acta radiologica.

[16]  P. Glass,et al.  Evaluation of Pentamorphone in Humans: A New Potent Opiate , 1989, Anesthesia and analgesia.

[17]  P. Glass,et al.  Is the Priming Principle Both Effective and Safe? , 1989, Anesthesia and analgesia.

[18]  J. Boggan,et al.  Intrathecal morphine delivered via subcutaneous pump for intractable cancer pain: a review of the literature. , 1999, Surgical neurology.